CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 Indaptus Therapeutics, Inc. - INDP CFD

    -
    0%
    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 -
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.024874%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.002651%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    关键数据
    前收盘价* N/A
    开盘价* N/A
    1 年变化* N/A
    日范围* N/A
    52 周范围 1.25-4.19
    平均交易量（10 天） 9,410.00
    平均交易量（3 个月) 171.47K
    市值 14.87M
    市盈率 -100.00K
    流通股 8.40M
    收入 N/A
    EPS -1.73
    股息（收益率 %） N/A
    贝塔 1.19
    下一个财报发布日期 N/A

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平倉 Change Change (%) 開倉 High Low

    Indaptus Therapeutics, Inc. Events

    時間（協調世界時） (UTC) 國家 事件
    No events scheduled
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 0 0 0 0 0
    收入
    总营业费用 14.9109 7.72911 13.829 47.109 43.328
    销售/一般/行政费用，总计 8.58625 5.20596 7.089 8.287 7.926
    研究与开发 6.32466 2.52315 6.74 26.659 35.402
    Depreciation / Amortization
    利息费用（收入) - 净运营
    Other Operating Expenses, Total 0 -1.5
    营业收入 -14.9109 -7.72911 -13.829 -47.109 -43.328
    利息收入（费用），非经营净值 0.01772 -0.165 0.163 -0.089
    税前净收入 -14.3228 -7.71139 -14.004 -46.961 -43.44
    税后净收入 -14.3228 -7.71139 -14.128 -47.599 -43.543
    未计算非常项目前的净收益 -14.3228 -7.71139 -14.128 -47.599 -43.543
    净收入 -14.3228 -7.71139 -14.128 -47.599 -43.543
    普通股股东可获收益 (不含非经常性项目) -14.3228 -7.71139 -14.128 -47.599 -43.543
    普通股股东可获收益 (含非經常性項目) -14.3228 -7.71139 -14.128 -47.599 -43.543
    摊薄净收入 -14.3228 -7.71139 -14.128 -47.599 -43.543
    摊薄后加权平均股 8.26212 4.0906 0.86525 0.4222 0.38991
    扣除特别项目的每股摊薄盈利 -1.73355 -1.88515 -16.3282 -112.74 -111.674
    每股正常摊薄盈利 -1.73355 -1.88515 -16.3282 -91.7055 -111.674
    其他，净值 0.58811 -0.01 -0.015 -0.023
    异常费用（收入） 0 13.663
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    总收入 0 0 0 0 0
    总营业费用 4.08702 3.55255 3.86926 3.40207 3.2185
    销售/一般/行政费用，总计 2.17518 1.943 2.3631 2.10498 2.27386
    研究与开发 1.91184 1.60955 1.50617 1.2971 0.94464
    营业收入 -4.08702 -3.55255 -3.86926 -3.40207 -3.2185
    其他，净值 0.43125 0.08618 0.03376 0.03692
    税前净收入 -3.65578 -3.46637 -3.8355 -3.36515 -3.21632
    税后净收入 -3.65578 -3.46637 -3.8355 -3.36515 -3.21632
    未计算非常项目前的净收益 -3.65578 -3.46637 -3.8355 -3.36515 -3.21632
    净收入 -3.65578 -3.46637 -3.8355 -3.36515 -3.21632
    普通股股东可获收益 (不含非经常性项目) -3.65578 -3.46637 -3.8355 -3.36515 -3.21632
    普通股股东可获收益 (含非經常性項目) -3.65578 -3.46637 -3.8355 -3.36515 -3.21632
    摊薄净收入 -3.65578 -3.46637 -3.8355 -3.36515 -3.21632
    摊薄后加权平均股 8.27269 8.2586 8.2586 8.2586 8.28409
    扣除特别项目的每股摊薄盈利 -0.44191 -0.41973 -0.46443 -0.40747 -0.38825
    Dividends per Share - Common Stock Primary Issue 0 0 0
    每股正常摊薄盈利 -0.44191 -0.41973 -0.46443 -0.40747 -0.38825
    利息收入（费用），非经营净值 0.00217
    • 年度
    • 每季度
    2021 2020 2019 2018 2017
    流动资产总额 40.3872 14.968 13.745 43.565 56.343
    现金和短期投资 39.1322 14.671 10.062 40.579 55.218
    现金等价物 39.1322 14.671 9.292 39.246 53.393
    短期投资 0.77 1.333 1.825
    应收账款总额，净额 0.085 3.486 2.031 0.478
    Accounts Receivable - Trade, Net 0.085 3.486 2.031 0.478
    Other Current Assets, Total 0.1484
    Total Assets 40.5766 20.896 21.28 61.51 64.549
    Property/Plant/Equipment, Total - Net 0.17289 2.211 3.818 12.233 8.206
    Total Current Liabilities 4.60414 5.334 8.342 7.656 5.747
    Payable/Accrued 4.50768 0.368 3.507 2.849 1.854
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 4.37 4.835 0.02 0.033
    Total Liabilities 4.677 6.363 9.745 7.965 5.747
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 0.07286 1.029 1.403 0.309 0
    Total Equity 35.8996 14.533 11.535 53.545 58.802
    Common Stock 0.08259 0.727 0.727 0.727 0.727
    Additional Paid-In Capital 51.4879 217.357 200.231 194.642 156.356
    Retained Earnings (Accumulated Deficit) -15.6709 -203.551 -189.423 -141.824 -98.281
    Other Equity, Total
    Total Liabilities & Shareholders’ Equity 40.5766 20.896 21.28 61.51 64.549
    Total Common Shares Outstanding 8.2586 1.08032 0.44865 0.41541 0.32595
    Prepaid Expenses 1.10665 0.212 0.197 0.955 0.647
    Property/Plant/Equipment, Total - Gross 10.61 11.014 18.575 13.689
    Accumulated Depreciation, Total -8.399 -7.196 -6.342 -5.483
    Other Long Term Assets, Total 0.01648 3.717 3.717 5.712 0
    Accrued Expenses 0.09647 0.596 4.787 3.86
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    流动资产总额 36.9197 40.3872 43.8549 18.792 12.159
    现金和短期投资 36.1778 39.1322 41.8572 16.991 10.135
    现金等价物 33.2163 39.1322 41.8572 16.991 10.135
    Prepaid Expenses 0.74195 1.10665 1.39767 0.801 1.024
    Other Current Assets, Total 0 0.1484 0.6 1 1
    Total Assets 37.0866 40.5766 43.8592 20.092 17.43
    Property/Plant/Equipment, Total - Net 0.15037 0.17289 0.00434 0 1.554
    Other Long Term Assets, Total 0.01648 0.01648 1.3 3.717
    Total Current Liabilities 3.67966 4.60414 5.78018 5.44 5.203
    Payable/Accrued 0.40032 4.50768 5.78018 0.397 0.183
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 5.043 5.02
    Total Liabilities 3.73017 4.677 5.78018 6.156 6.086
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 0.05052 0.07286 0.716 0.883
    Total Equity 33.3564 35.8996 38.079 13.936 11.344
    Common Stock 0.08259 0.08259 0.08133 0.727 0.727
    Additional Paid-In Capital 52.3191 51.4879 50.4523 228.421 218.397
    Retained Earnings (Accumulated Deficit) -19.036 -15.6709 -12.4546 -215.212 -207.78
    Total Liabilities & Shareholders’ Equity 37.0866 40.5766 43.8592 20.092 17.43
    Total Common Shares Outstanding 8.2586 8.2586 8.13324 1.85874 1.12565
    Accrued Expenses 0.44466 0.09647
    短期投资 2.96146
    Accounts Payable 2.83468
    Other Equity, Total -0.00922
    • 年度
    • 每季度
    2021 2020 2019 2018 2017
    净收入/起跑线 -7.71139 -14.128 -47.599 -43.543 -28.909
    经营活动产生的现金 -11.2905 -11.511 -29.045 -39.076 -22.132
    经营活动产生的现金 0.0014 1.203 0.854 0.859 0.829
    非现金物品 1.49378 1.001 17.192 4.25 0.858
    营运资金的变化 -5.07433 0.413 0.508 -0.642 5.09
    投资活动产生的现金 0.44775 0.75 -3.21 -9.301 -4.747
    资本支出 -0.00385 -0.022 -0.921 -4.667 -5.001
    其他投资现金流量项目，总计 0.4516 0.772 -2.289 -4.634 0.254
    融资活动产生的现金 48.3375 15.978 2.368 35.059 63.707
    股票的发行（报废），净额 27.6565 15.907 2.368 35.059 63.707
    外汇效应 0.162 -0.067 -0.829 0.127
    现金净变化 37.4947 5.379 -29.954 -14.147 36.955
    Cash Taxes Paid 0.0008 0.009 0.075 0.096 0
    融资现金流项目 20.681 0.071
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line -3.36515 -7.71139 -4.49506 -11.661 -0.61242
    Cash From Operating Activities -3.11773 -11.2905 -7.75082 -7.397 -0.82558
    Cash From Operating Activities 0.00053 0.0014 0.00087 1.178 0.00021
    Non-Cash Items 0.80703 1.49378 0.83646 3.493 0.02045
    Cash Taxes Paid 0 0.0008 0.0008 0.01 0.0008
    Changes in Working Capital -0.56014 -5.07433 -4.09308 -0.407 -0.23382
    Cash From Investing Activities -2.79813 0.44775 -0.00385 0 0
    Other Investing Cash Flow Items, Total -2.79813 0.4516 0 0
    Cash From Financing Activities 0 48.3375 47.9744 10.856 3.675
    Financing Cash Flow Items 0 20.681 20.681 3.675
    Net Change in Cash -5.91585 37.4947 40.2197 3.32 2.84942
    Capital Expenditures -0.00385 -0.00385 0
    Issuance (Retirement) of Stock, Net 27.6565 27.2934 10.856
    Foreign Exchange Effects -0.139
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    Newman (Michael James) Individual Investor 16.2879 1368356 0 2022-08-03 LOW
    Anderson (Glen R) Individual Investor 12.9394 1087048 348956 2022-07-07 MED
    Lee (Hoonmo) Individual Investor 8.2671 694522 0 2021-09-29
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.98 250348 101 2022-12-31 LOW
    The Investment House LLC Investment Advisor 1.1383 95629 0 2022-12-31 LOW
    Meckler (Jeffrey A) Individual Investor 0.8972 75374 10000 2022-11-21 LOW
    Strategy Asset Managers, L.L.C. Investment Advisor 0.6587 55336 0 2022-12-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.6014 50521 -101 2022-12-31 LOW
    Stratos Wealth Partners, Ltd. Investment Advisor 0.3194 26832 0 2022-12-31 LOW
    Vivaldi Capital Management, LLC Investment Advisor/Hedge Fund 0.2857 24000 0 2022-12-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.2318 19473 0 2022-12-31 LOW
    Renaissance Technologies LLC Hedge Fund 0.2274 19100 -600 2022-12-31 HIGH
    Susquehanna International Group, LLP Investment Advisor 0.1725 14495 14495 2022-12-31 MED
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1141 9587 0 2022-12-31 LOW
    Tower Research Capital LLC Hedge Fund 0.0803 6742 6418 2022-12-31 HIGH
    Northern Trust Global Investments Investment Advisor 0.0394 3311 0 2022-12-31 LOW
    Litchev (Boyan Vesselinov) Individual Investor 0.0137 1150 500 2022-12-01 HIGH
    Maddaluna (Anthony J) Individual Investor 0.008 670 0 2022-08-03 LOW
    Bangor Savings Bank Bank and Trust 0.0048 400 0 2022-12-31 LOW
    Morgan Stanley & Co. LLC Research Firm 0.0043 365 0 2022-12-31 MED

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    500K+

    交易者

    92K+

    每月活跃客户

    $53M+

    每月投资额

    $30M+

    每月提取金额

    交易計算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    貿易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投資
    交易規模（槓桿 x 投資）：
    開倉

    平倉

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/失利

    Indaptus Therapeutics, Inc. Company profile

    关于 Indaptus Therapeutics Inc.

    Indaptus Therapeutics公司，前身为Intec Parent公司，提供免疫疗法来治疗疾病。 该公司致力于开发临床前的候选治疗药物，以产生抗肿瘤和抗病毒反应并治愈疾病。 它通过瞄准特定的肿瘤或病毒抗原来设计其方法。 其主要候选药物Decoy20正处于临床前开发阶段。 其平台是基于这样的假设：要求抗肿瘤免疫疗法同时激活肿瘤和免疫器官的先天和适应性细胞免疫。 其方法是使用多靶点的细菌病原体相关分子模式（PAMPs）包，以减弱和杀死的形式，将完整但不致病的细菌静脉注射。 它的静脉治疗候选药物针对肝脏、脾脏和肿瘤的渗漏血管，在一个免疫器官中产生免疫激活，以及原发性和转移性癌症和乙型肝炎病毒（HBV）感染的共同部位。

    Industry: Biotechnology & Medical Research (NEC)

    3 Columbus Circle
    15Th Floor
    10019

    收入报表

    • Annual
    • Quarterly

    人们也观看

    Gold

    1,969.66 Price
    -0.550% 1D Chg, %
    多头隔夜费 -0.0185%
    空头隔夜费 0.0102%
    隔夜费时间 21:00 (UTC)
    价差 0.30

    US100

    13,186.80 Price
    +1.680% 1D Chg, %
    多头隔夜费 -0.0249%
    空头隔夜费 0.0027%
    隔夜费时间 21:00 (UTC)
    价差 3.0

    Natural Gas

    2.20 Price
    +3.540% 1D Chg, %
    多头隔夜费 -0.4092%
    空头隔夜费 0.3873%
    隔夜费时间 21:00 (UTC)
    价差 0.005

    Oil - Crude

    75.76 Price
    +1.830% 1D Chg, %
    多头隔夜费 -0.0156%
    空头隔夜费 -0.0063%
    隔夜费时间 21:00 (UTC)
    价差 0.03

    还在找一位您可以信任的经纪商吗？

    加入成为全球500,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易